Golumbeski George

Director

BoardM

US·SEC (Form 4)

Shattuck Labs, Inc.Sage Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Companies

€424,012

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by Golumbeski George, Director. Insider active across 2 companies, notably Shattuck Labs, Inc.. In total, 3 filings have been recorded. Total volume traded: €424k. The latest transaction was disclosed on 5 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.

Declarations3 total

Executives▲PurchaseSSage Therapeutics, Inc.23SEC

G

Golumbeski GeorgeDirector

€238,6818,000 shares@ €29.8351100.0% of flow

Common Stock

SEC:0001562180-22-003898:0·5 May 2022

Ideal exit: 30 Jan 2023 (T+270)

SEC ↗

Executives▲PurchaseSShattuck Labs, Inc.28SEC

G

Golumbeski GeorgeDirector

€96,61928,330 shares@ €3.41050.020% mcap52.1% of flow

Common Stock

SEC:0000899243-22-015764:0·26 Apr 2022

Ideal exit: 21 Jan 2023 (T+270)

SEC ↗

Executives▲PurchaseSShattuck Labs, Inc.26SEC

G

Golumbeski GeorgeDirector

€88,71226,049 shares@ €3.40560.018% mcap47.9% of flow

Common Stock

SEC:0000899243-22-015609:0·21 Apr 2022

Ideal exit: 16 Jan 2023 (T+270)

SEC ↗

3 of 3 declarations

About Golumbeski George

George Golumbeski is a Director at Shattuck Labs, Inc. and Sage Therapeutics, Inc. In these roles, he participates in the governance of the companies and strategic decision-making. Golumbeski brings expertise in biotechnology and drug development, contributing to innovation and performance at the companies.